Alert share

Date of changeSharesDirector/
Substantial Shareholder
14 Oct 2021Acquired
650,000
Pang Wee See
13 Oct 2021Acquired
650,000
Mr Pang Wee See
13 Oct 2021Acquired
650,000
Yee Oii Pah @ Yee Ooi Wah
07 Sep 2021Acquired
630,000
Pang Wee See
07 Sep 2021Acquired
630,000
Mr Pang Wee See
07 Sep 2021Acquired
630,000
Yee Oii Pah @ Yee Ooi Wah
19 May 2020Acquired
919,000
Tan Boon Kok
19 May 2020Acquired
919,000
Mr Tan Boon Kok
10 Jan 2020Acquired
2,057,120
Yee Oii Pah @ Yee Ooi Wah
10 Jan 2020Acquired
2,057,120
Pang Wee See


Date Title
15 Oct 2021 Changes in Director's Interest (Section 219 of CA 2016) - PANG WEE SEE
15 Oct 2021 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR PANG WEE SEE
15 Oct 2021 Changes in Director's Interest (Section 219 of CA 2016) - YEE OII PAH @ YEE OOI WAH
23 Sep 2021 Change of Address
08 Sep 2021 Changes in Director's Interest (Section 219 of CA 2016) - PANG WEE SEE
08 Sep 2021 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR PANG WEE SEE
08 Sep 2021 Changes in Director's Interest (Section 219 of CA 2016) - YEE OII PAH @ YEE OOI WAH
27 Aug 2021 Quarterly rpt on consolidated results for the financial period ended 30/06/2021
14 Jun 2021 BTECH - Notice of Book Closure
11 Jun 2021 Final Dividend


09 Oct Top Glove, AirAsia, Brite-Tech, Censof, MyEG, Euro Holdings, UMW, Pestech and...
08 Oct Brite-Tech to acquire two pieces of land in Klang for RM10m
11 Aug Brite-Tech unaware of reasons for UMA
10 Aug Avi, BIG, BTech, BTM, Compugt, Fintec, GPA, iDimension, Jiankun, JKGLand, Johan...
06 Jan Alam, Ancom, Brite-Tech, Freight, Icon, Oka, Tadmax, Willow
24 Dec Engtex, GDB, RSawit, BTech, JCY, PinePac
18 Mar Crest Builder, L&G, Brite-Tech, Carimin, Destini, Federal International, LB...
21 Feb BioOsmo, BTech, Camres, Dayang, Dolphin, Ekovest, Fajarbaru, Favco, Gadang,...
14 Nov K1, Tadmax, B-Tech, Permaju, AKnight
13 Nov Guan Chong, Permaju, Asia Knight, Brite-Tech, Merge, Hoover
24 Sep 陈亚健售股退场‧利达新股东引关注
20 Sep 利达前执行董事售8.23%
19 Feb Ex-director sues Brite-Tech for alleged breach of confidence
15 Feb CCM Duopharma seeks to commercialise erythopoietin for kidney failure treatment


ANNUAL REPORT 2020

ANNUAL REPORT 2019

ANNUAL REPORT 2018

ANNUAL REPORT 2017

ANNUAL REPORT 2016

ANNUAL REPORT 2015

ANNUAL REPORT 2014

ANNUAL REPORT 2013

ANNUAL REPORT 2012

ANNUAL REPORT 2011



Like
valueinvestor1 and 2 others like this company.
Overview Market Search portfolio More
Overview Market Search Portfolio More
Recently Viewed